Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,465.15
1,661.29
1,550.18
1,377.96
1,467.07
1,783.30
1,400.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,465.15
1,661.29
1,550.18
1,377.96
1,467.07
1,783.30
1,400.24
Raw Material Cost
1,144.49
1,354.05
1,116.10
1,130.46
1,201.09
1,392.38
1,021.94
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.92
16.51
18.22
20.39
17.73
19.03
24.02
Selling and Distribution Expenses
141.77
180.23
198.26
148.40
155.54
249.34
183.82
Other Expenses
4.43
4.42
6.76
3.57
5.05
5.17
8.14
Total Expenditure (Excl Depreciation)
1,347.48
1,595.00
1,400.19
1,334.98
1,424.92
1,712.42
1,311.20
Operating Profit (PBDIT) excl Other Income
117.69999999999999
66.3
150
43
42.199999999999996
70.9
89
Other Income
18.35
21.24
2.04
22.28
224.42
29.13
32.25
Operating Profit (PBDIT)
181.03
210.10
186.16
178.23
356.33
198.21
172.13
Interest
16.92
16.51
18.22
20.39
17.73
19.03
24.02
Exceptional Items
-0.07
0.00
-0.02
0.20
-0.08
-0.07
-0.08
Gross Profit (PBDT)
320.66
307.23
434.08
247.51
265.97
390.91
378.30
Depreciation
106.26
106.26
104.59
104.59
96.42
96.42
93.51
Profit Before Tax
57.78
87.33
63.33
53.45
242.10
82.69
54.51
Tax
28.60
3.68
10.14
1.20
4.25
9.95
-5.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.24
78.60
47.56
47.10
232.65
67.31
53.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.24
78.60
47.56
47.10
232.65
67.31
53.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.06
3.75
3.87
3.11
3.09
3.66
3.22
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.30
82.35
51.43
50.21
235.74
70.97
56.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,944.15
3,995.58
3,918.19
3,893.47
3,853.07
3,679.35
3,611.70
Earnings per share (EPS)
0.03
0.09
0.05
0.05
0.26
0.08
0.06
Diluted Earnings per share
0.03
0.09
0.05
0.05
0.26
0.08
0.06
Operating Profit Margin (Excl OI)
3.85%
4.97%
5.13%
3.73%
2.42%
4.08%
3.31%
Gross Profit Margin
11.2%
11.65%
10.83%
11.47%
23.07%
10.04%
10.57%
PAT Margin
1.93%
4.73%
3.07%
3.42%
15.86%
3.77%
3.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -11.80% vs 7.17% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -65.61% vs 60.12% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -13.87% vs 2.61% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 2.42% vs -9.34% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Shandong Lukang Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,465.15
0
1,465.15
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,465.15
0
1,465.15
Raw Material Cost
1,144.49
0
1,144.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
16.92
0
16.92
Selling and Distribution Expenses
141.77
0
141.77
Other Expenses
4.43
0.00
4.43
Total Expenditure (Excl Depreciation)
1,347.48
0
1,347.48
Operating Profit (PBDIT) excl Other Income
117.67
0.00
117.67
Other Income
18.35
0
18.35
Operating Profit (PBDIT)
181.03
0
181.03
Interest
16.92
0
16.92
Exceptional Items
-0.07
0
-0.07
Gross Profit (PBDT)
320.66
0
320.66
Depreciation
106.26
0
106.26
Profit Before Tax
57.78
0
57.78
Tax
28.60
0
28.60
Provisions and contingencies
0
0
0.00
Profit After Tax
28.24
0
28.24
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.24
0
28.24
Share in Profit of Associates
0
0
0.00
Minority Interest
0.06
0
0.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.30
0
28.30
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,944.15
0
3,944.15
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
3.85%
0%
0.00
3.85%
Gross Profit Margin
11.20%
0%
0.00
11.20%
PAT Margin
1.93%
0%
0.00
1.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 146.52 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -11.80% vs 7.17% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -0.13% vs -2.45% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.83 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -65.61% vs 60.12% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -87.99% vs 166.93% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.27 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -13.87% vs 2.61% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 23.35% vs -5.99% in Jun 2024
Quarterly - Interest
Interest 1.69 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 2.42% vs -9.34% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -4.52% vs 20.41% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.85%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
